Mitochondrial fusion

pathway activity — cross-omics
GO:0008053Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Mitochondrial fusion pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are TRIM22, NEXN, and FLT3, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Mitochondrial fusion activity versus TRIM22 in LSCC (Pearson r = -0.23).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCTRIM22 →-0.634-0.165.001<.00136
OVNEXN →-0.940-0.160.006.00327
PDACFLT3 →-0.542-0.217.003.00835
LUADLINC00702 →-0.277-0.141.002.00435
CCRCCMYH14 →+0.861+0.179.005<.00135
CCRCCPTPRB →-0.674-0.166<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0008053 vs TRIM22 — LSCC

Per-sample scatter of Mitochondrial fusion activity vs TRIM22 in LSCC.

Explore this scatter interactively →

Exploration